Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Lucero
Lucero AB develops the first ready-to-use 3D cell culture product specifically designed for pharmaceutical drug development. Their key product is a cryopreserved assay-ready liver spheroid plate that…
Lucero
Lucero AB develops the first ready-to-use 3D cell culture product specifically designed for pharmaceutical drug development. Their key product is a cryopreserved assay-ready liver spheroid plate that…
TL;DR
Founded: 2020
Headquarters: Gothenburg, Sweden
Product: Thaw-and-dose assay-ready 3D liver spheroid plates for high-throughput drug discovery
Tech focus: Microfluidics, optics, AI for QC and plate preparation
Commercial milestone: Preparing for product launch in 2026
Company Overview
Problem Domain
Preclinical drug discovery (early-stage ADME, toxicity, and PK/PD testing)
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
Latest disclosed round on Crunchbase reported as Pre-Seed (Mar 22, 2022).
Investor Signal
“Chalmers Ventures AB (lead investor); YES!Delft listed among investors; recipient of multiple European grants (ERC PoC, Vinnova, EIC Transition).”